Ionpath + press release
Web1 jan. 2024 · Ionpath® is a registered trademark and MIBI™ & MIBIscope™ are trademarks of Ionpath, Inc. For Research Use Only. Not for use in diagnostic procedures. Contact … Web8 nov. 2024 · Several studies highlight utility of Ionpath’s multiplexed ion beam imaging (MIBI) technology in spatial proteomics applications. MENLO PARK, Calif.--(BUSINESS WIRE)--Ionpath, a pioneer in high-definition spatial proteomics, today announced that the results of several studies enabled by multiplexed ion beam imaging (MIBI™) technology …
Ionpath + press release
Did you know?
Web20 aug. 2024 · MENLO PARK, Calif., Aug. 20, 2024 /PRNewswire/ -- IONpath, Inc., the leader in high-definition spatial proteomics, today announced the appointment of Sander Gubbens, PhD, as its new CEO. Dr.... WebIONpath is a California-based biotechnology company that manufactures and supplies spatial proteomics and tissue imaging systems for the healthcare industry. IONpath’s …
Web1 nov. 2024 · Accomplished scientist and business executive brings nearly two decades of experience working on commercial strategies and operations in life sciences MENLO PARK, Calif. — Ionpath, a pioneer in high-definition spatial proteomics, announced today that Goran Pljevaljcic has joined the company as its Chief Commercial Officer. In this … Web10 mei 2024 · IonPath, Inc. announced that it will issue 70,531,242 voting series C preferred shares at a price of $1.0455 per share for the gross proceeds of …
Web24 sep. 2024 · MENLO PARK, Calif., Sept. 24, 2024 /PRNewswire/ -- IONpath, Inc., the leader in high-definition spatial proteomics, today announced the close of a $18 million … Web11 mei 2024 · MENLO PARK, Calif.-- (BUSINESS WIRE)-- #oncology --Ionpath, Inc., a leader in high-definition spatial proteomics, today announced that Thermo Fisher Scientific, the world leader in serving science, has made a strategic investment in the company. Details of the investment are not being disclosed.
WebIonpath’s MIBI™ (multiplexed ion beam imaging) platform breaks through the limitations of traditional immunohistochemistry (IHC), enabling a deeper understanding of the tissue microenvironment with highly multiplexed, quantitative single-cell analysis.
Web20 aug. 2024 · (2024-08-20) IONpath Appoints Sander Gubbens, PhD, as Chief Executive Officer (2024-08-20) IONpath Appoints Sander Gubbens, PhD, as Chief Executive Officer. Stockhouse.com uses cookies on this site. ... We will not release or resell your information to third parties without your permission. earth day logo 2022WebIonpath General Information Description Developer of an ion beam imaging technology designed to offer tissue imaging and analysis to accelerate discovery and improve … earth day long beachWebIonpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies. Its imaging technology surpasses light microscopy to analyze whether the … ctfhud refer注入Web8 nov. 2024 · MENLO PARK, Calif.--(BUSINESS WIRE)--Ionpath, a pioneer in high-definition spatial proteomics, today announced that the results of several studies enabled … earth day logo clip artWebMultiplexed Ion Beam Imaging (MIBI™) technology from Ionpath enables high-definition spatial proteomics that uniquely provides actionable analysis of the tissue microenvironment—delivering novel insights into disease … ctfhutWeb11 feb. 2024 · MENLO PARK, California, Feb. 11, 2024 /PRNewswire/ — IONpath, Inc., today announces the launch of a dedicated service business providing access to their proprietary MIBIscope™ multiplexed imaging platform and its team of experts to support pharmaceutical and biotechnology companies working in immuno-oncology. IONpath … ctf huffmanWebMIBI™ technology (Multiplexed Ion Beam Imaging) uses Secondary-Ion Mass Spectrometry (SIMS), a type of mass spectrometry traditionally used in the semiconductor industry, to image antibodies tagged with monoisotopic metal reporters. This unique technology enables: Visualization of 40+ markers simultaneously. Imaging at the sub … earth day love our planet